ChromaDex Corporation (CDXC)
NASDAQ: CDXC · Real-Time Price · USD
5.49
+0.08 (1.48%)
Dec 20, 2024, 4:00 PM EST - Market closed
ChromaDex Employees
ChromaDex had 106 employees as of December 31, 2023. The number of employees decreased by 7 or -6.19% compared to the previous year.
Employees
106
Change (1Y)
-7
Growth (1Y)
-6.19%
Revenue / Employee
$864,792
Profits / Employee
$14,009
Market Cap
420.26M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Village Super Market | 7,300 |
Nu Skin Enterprises | 3,700 |
Calavo Growers | 3,064 |
SNDL Inc. | 2,516 |
Oatly | 1,548 |
Lifeway Foods | 289 |
Limoneira Company | 257 |
CDXC News
- 18 days ago - ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category - Business Wire
- 5 weeks ago - ChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement - Business Wire
- 6 weeks ago - ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide - Business Wire
- 7 weeks ago - ChromaDex Corporation (CDXC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - ChromaDex Corporation Reports Third Quarter 2024 Financial Results - Business Wire
- 7 weeks ago - ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 - Business Wire
- 2 months ago - ChromaDex to Participate in the 17th Annual LD Micro Main Event - Business Wire
- 2 months ago - Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) - Business Wire